Ergomed hosted a very interesting investor meeting yesterday, providing an overview of the business with a particular focus on PrimeVigilance. We continue to believe Ergomed’s specialised service offering provides it with a substantial opportunity to generate attractive returns for shareholders with significant upside from the development business. The group has grown considerably over the years (37% 3 year revenue CAGR to Dec 2016) and we estimate continued double-digit service growth in our fo ....
